v3.3.0.814

Condensed Balance Sheets (Unaudited) - USD ($)	Sep. 30, 2015	Dec. 31, 2014
CURRENT ASSETS
Cash	$ 498,101	$ 716,193
Prepaid expenses	7,152
Total Current Assets	505,253	$ 716,193
TOTAL ASSETS	505,253	716,193
CURRENT LIABILITIES
Accounts payable and accrued expenses	303,462	447,999
Total Current Liabilities	303,462	447,999
STOCKHOLDERS’ EQUITY
Common stock; $0.001 par value, 50,000,000 shares authorized; 14,163,887 and 14,123,887 shares issued and outstanding, respectively	14,164	14,124
Accrued dividends	1,530,429	969,230
Additional paid-in capital	13,435,837	12,700,365
Accumulated deficit	(14,779,840)	(13,416,598)
Total Stockholders' Equity	201,791	268,194
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY	505,253	716,193
Convertible Preferred Stock Series A [Member]
STOCKHOLDERS’ EQUITY
Preferred Stock	326	326
Convertible Preferred Stock Series B [Member]
STOCKHOLDERS’ EQUITY
Preferred Stock	215	215
Convertible Preferred Stock Series C [Member]
STOCKHOLDERS’ EQUITY
Preferred Stock	500	500
Convertible Preferred Stock Series D [Member]
STOCKHOLDERS’ EQUITY
Preferred Stock	$ 160	$ 32

Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.

SignPath Pharma, Inc. 10-Q